Skip to main content
915 TLDR
Health
1 read

Viatris Inc. Issues Nationwide Recall of Extended-Release Xanax Tablets

KTSMMatthew Euzarraga
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KTSM

Read Original

AI Summary

Viatris Inc. has announced a voluntary recall of a particular lot of extended-release Xanax (alprazolam) tablets due to safety concerns. This recall is significant as it affects consumers who rely on this medication for anxiety management. The recall underscores the importance of monitoring pharmaceuticals for quality and safety. Patients using this medication should check their prescriptions against the recalled lot and consult with healthcare providers if they have any concerns.

health recall pharmaceuticals xanax viatris

People & Organizations

Viatris Inc.

Related Articles